Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Realize 365 Joins #HISA2026 as Gold Sponsor Ahead of Major Healthcare Summit
Realize 365 has stepped up as a Gold Sponsor for the Healthcare Innovation Summit Africa 2026 (HISA2026), scheduled for May 28‑29 in Johannesburg’s Indaba Hotel Conference Centre. The conference will convene CIOs, policymakers, AI specialists, and cybersecurity experts to chart the continent’s digital health future. Realize 365’s clinical‑intelligence platform promises to condense complex medical records into a 60‑second, interactive patient story. Attendees can claim a 25% discount with the coupon code “SAVE25@HISA.”
Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
Brainomix and Boehringer Ingelheim have expanded their partnership to accelerate diagnosis of progressive pulmonary fibrosis (PPF) using Brainomix's FDA‑cleared AI platform, e‑Lung. A retrospective study (REVISE‑PPF) showed e‑Lung could identify patients at risk up to 28 months before standard clinical...
Tolion Health AI Launches AI-Powered Tolion Brain Coach App for Brain Health, Longevity, and Prevention of Alzheimer’s Disease
Tolion Health AI unveiled the Tolion Brain Coach, an AI‑driven mobile app that extends its Brain Health Platform with personalized, preventive insights for cognitive wellness. The app pulls data from Apple Health and Google Health Connect, analyzing more than 15...
Dr Reddy's Laboratories Q4 Results: Cons PAT Falls 86% YoY to Rs 221 Crore, Revenue Dips 12%; Rs 8 per...
Dr Reddy's Laboratories posted a consolidated net profit of Rs 221 crore (≈ $27 million) in Q4 FY26, an 86% YoY plunge from Rs 1,587 crore. Revenue fell 12% YoY to Rs 7,516 crore (≈ $904 million) and gross margin slipped to 44.8%, down 1,074 bps year‑on‑year. The board proposed a final...
SANA Adds CD8‑targeted Fusosome SG227 to Pipeline
🚨! $SANA has just reported - in its Q1 ER, that it plans to expand its pipeline by advancing a new preclinical program - SG227. SG227 is a CD8-targeted fusosome that by delivering a genetic material to make BCMA-directed CAR...
Surgery May Worsen Knee Osteoarthritis, Study Says, so What Could Help?
A Finnish study published in The New England Journal of Medicine found that arthroscopic partial meniscectomy, a common surgery for knee osteoarthritis, leads to worse outcomes over a decade compared with sham procedures. Patients who underwent the meniscus‑removing surgery experienced...
FDA Approves First AI Test to Guide Breast Cancer Chemotherapy Decisions
The U.S. Food and Drug Administration has cleared ArteraAI Breast, the first artificial‑intelligence test designed to guide chemotherapy decisions for early‑stage, hormone‑receptor‑positive, HER2‑negative breast cancer. The digital‑pathology platform scans resection slides, combines them with clinical variables, and uses a multimodal...
Health Ministry Calls Off Long-Delayed Maran Hospital Project
Malaysia's Health Ministry has shelved the long‑delayed Maran Hospital project, despite a RM350 million (≈$77 million) allocation in the 2023 Budget and a prior RM150 million (≈$33 million) commitment under the 11th Malaysia Plan. Minister Datuk Seri Dr Dzulkefly Ahmad cited low bed‑occupancy rates—57%...
U.S. Lawmakers Push FDA to Fast‑Track Psychedelic Therapies for Mental Health
A bipartisan group of 32 House members, led by Reps. Jack Bergman and Lou Correa, sent a May 1 letter to FDA Commissioner Martin Makary urging the agency to speed up evaluation of psychedelic‑based treatments for PTSD, depression and substance‑use disorders. The...
Survey Finds 75% of Parents, Voters Back Comprehensive Youth Mental‑Health Plans
The Coalition to Empower our Future released research showing 75% of parents and voters support comprehensive approaches to youth mental health, while 71% of voters and 79% of parents oppose bans on phones and social media. The findings, based on...
U.S. Birth Rate Falls as Trump Administration Rolls Out $1,000 Baby Bonus
The United States saw its birth rate dip further in the latest CDC report, even as the Trump administration unveiled a $1,000 baby bonus and expanded IVF subsidies. Officials argue the measures will reverse a 20‑year demographic decline, but early...
Novo Says High-Dose Wegovy Can Cause 28% Weight Loss
Novo Nordisk reported that its high‑dose 7.2 mg Wegovy formulation enabled early responders to lose nearly 28 % of body weight in the 72‑week STEP UP trial. Across the 1,400‑patient study, average weight loss reached 21 %, with 27 % of participants qualifying as early...
Global Study Shows Psychedelics Disrupt Brain's Hierarchical Organization
Researchers from a consortium of universities reported that psychedelics dissolve the brain's hierarchical organization, a finding that could reshape therapeutic approaches to creativity, mental health and self‑exploration. The study, published this week, analyzed brain‑imaging data from participants across several continents.
BridgeBio’s Attruby Challenges Pfizer’s Vyndamax Legacy in Pivotal ATTR Trial
BridgeBio unveiled pivotal Phase III ATTRibute‑CM data for its FDA‑approved drug Attruby at the ESC 2026 Heart Failure congress. The study showed sustained wild‑type transthyretin levels, a 40% drop in outpatient worsening heart‑failure events, and a 34% reduction in cardiovascular hospitalisations...
Researchers Develop Innovative Model for Risk Assessment for Hypertrophic Cardiomyopathy
A NIH‑funded international study of 2,700 hypertrophic cardiomyopathy (HCM) patients introduced a new risk‑assessment model that combines clinical history, contrast‑enhanced cardiac MRI, and NT‑proBNP blood biomarker data. Over a seven‑year follow‑up, the model more accurately predicted sudden cardiac death, heart‑failure...
Pancreatic Cancer Patient Vicky Stinson Survives Two Years on New Targeted Drug Daraxonrasib
Vicky Stinson, a 65‑year‑old pancreatic cancer patient, has survived two years after receiving daraxonrasib, a genetically targeted therapy that extended progression‑free survival to 8‑9 months—three to four times longer than standard chemotherapy. The drug’s trial results signal a potential shift...
Novo Nordisk Reports New STEP UP Trial Analyses on Wegovy 7.2mg for Weight Loss
Novo Nordisk presented new sub‑analyses from the STEP UP trial comparing its higher‑dose Wegovy 7.2 mg weekly injection with the approved 2.4 mg dose and placebo in over 1,400 obese adults without diabetes. Over 72 weeks, the 7.2 mg regimen produced an average 20.7%...
BMS, Hengrui Ink $15.2B Oncology Deal Covering 13 Programs
Bristol Myers Squibb and Hengrui Pharma have signed a global strategic collaboration that could be worth up to $15.2 billion, covering 13 early‑stage programs in oncology, hematology and immunology. The agreement gives BMS exclusive rights outside China and Hengrui exclusive rights...
If You’re Going to Remove the Clinician, You Have to Think Like a Clinician (and Ride Your Bike)
The author recounts a personal health alert after a bike ride, where his KardiaMobile 6L’s AI flagged a wide QRS complex despite a normal sinus rhythm history. A cardiologist’s overread deemed the reading normal, underscoring the tension between AI‑driven wearables...
US Government Studies Into Vaccine Safety Are Being Suppressed | Robert B Shpiner
The FDA withdrew two peer‑reviewed COVID‑19 vaccine safety studies—one analyzing 7.5 million Medicare beneficiaries and another covering 4.2 million recipients—after political appointees refused to sign off, despite journal acceptance. A separate Shingrix safety abstract was also blocked, even though it confirmed a...
Maximizing Drug Impact
Tris Pharmaceutical, founded by CEO Ketan Mehta, has evolved from an oral‑technology specialist to a broader portfolio that now includes pain‑management and addiction therapies. Mehta explained that the company tackles drug‑impact challenges by engineering particle‑based delivery systems that provide continuous,...
NHS Delays Affect Employees’ Ability to Do Their Job
A Health Shield Friendly Society poll of more than 2,000 UK employees found that 53% said NHS waiting times hampered their ability to work last year. The survey also revealed that 43% resorted to self‑treatment and 55% struggled to secure...
E‑Patients Redefine Healthcare’s Future at Budapest Symposium
The Future of Healthcare From an E-patient Perspective - Presentation by Dave deBronkart (USA)! The presentation took place in the first scientific symposium about medical futures studies at the Hungarian Academy of Sciences in Budapest, Hungary on the 10th of April,...
RIGL to Sell Approved Veppanu for ARVN, PFE
$RIGL will sell the newly approved Veppanu for $ARVN and $PFE. Modest financial terms https://t.co/9RsbSMzxBf
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
Daraxonrasib, a KRAS‑targeting drug, is on the brink of regulatory approval and has shown the first meaningful survival benefit for pancreatic cancer patients. The molecule binds a mutated KRAS protein long deemed “undruggable,” a breakthrough that also appears effective against...
Expensive AI Therapy Robot Might End Up Dishwasher
What if @DrPatrick builds an expensive AI robot to make NK cell therapies and then those therapies don’t work? I guess the robot could be reprogrammed to wash his dishes.
SMC Backs First-Line Metastatic Bladder Cancer Combination After Trial Results
Scotland’s Medicines Consortium (SMC) has approved reimbursement for the first‑line combination of enfortumab vedotin and pembrolizumab for adults with unresectable or metastatic urothelial cancer. The decision follows the phase 3 EV‑302 trial, which showed median overall survival of 33.8 months versus...
Inhibrx Announces Positive Interim Results From HexAgon Trial
Inhibrx Biosciences reported positive interim Phase II data from its HexAgon trial of INBRX‑106 combined with pembrolizumab in PD‑L1‑positive metastatic head and neck squamous cell carcinoma. In the evaluable cohort, the combination achieved a 44% objective response rate versus 21% with...
Media Spreads Hantavirus Hysteria In Attempt To Save Disgraced WHO
The media amplified a recent hantavirus case on a cruise from Argentina to West Africa, framing it as a looming public‑health crisis. The coverage coincides with the World Health Organization’s severe funding shortfall after the United States withdrew, leaving the...
Ex-NFL Player Sentenced to 16 Years in Prison for $200M Medicare Fraud Scheme
Former NFL tight end Rufus French received a 16‑year prison term for leading a multi‑year Medicare fraud that siphoned nearly $200 million. He coordinated overseas telemarketing call centers to harvest personal data from seniors and veterans, then sold falsified doctors’ orders...
EktaH Links Novel Obesity Drug to Fat Loss, Muscle Retention in Early-Phase Trial
EktaH disclosed early‑phase data for two oral candidates that activate fat‑taste receptors CD36 and GPR120, aiming to treat obesity by restoring lipid sensing. In a four‑week dose escalation study, the CD36/GPR120 agonist NKS‑5 reduced fat mass by 4.30% and modestly...
Ultrasound-Activated Nanoparticles Shine a Light Deep Within Living Tissues
Stanford researchers have demonstrated that ultrasound can activate mechanoluminescent nanoparticles to emit blue light deep within living tissue. By coating Sr4Al14O25:Eu,Dy particles with a biocompatible film and injecting them into mice, they produced programmable 490 nm illumination in organs such as...
Can Medical Schools Really Teach 71 Nutrition ‘Competencies’? Should They?
The U.S. Department of Health and Human Services unveiled a Medical Education Nutrition Competency Framework that outlines 10 domains and 71 specific competencies, requiring a minimum of 40 instructional hours for undergraduate medical students. HHS Secretary Robert F. Kennedy Jr....
Radiology Groups Urge Congress to Enact Penalties Against Payers Who Violate No Surprises Act
Radiology societies and other physician groups have urged Congress to pass the No Surprises Act Enforcement Act, a bipartisan bill that would increase penalties for insurers that refuse to pay after losing an independent dispute resolution (IDR) ruling. The legislation,...
RESEARCH: TOCOTRIENOLS in COLORECTAL CANCER - 2024 Review Paper From Malaysia
A 2024 review from Malaysia examined 38 peer‑reviewed articles on tocotrienols, a subclass of vitamin E, and their effects on colorectal cancer. The analysis highlighted two isoforms, gamma‑ and delta‑tocotrienol, which consistently inhibited tumor cell proliferation, induced apoptosis, and reduced metastatic...
Roche Gets Second European Approval for Alzheimer’s Test
Roche, in partnership with Eli Lilly, secured a CE mark for its second Elecsys blood test, the pTau217 assay, enabling sales across the European Economic Area. The new test can both confirm and exclude Alzheimer’s disease, expanding on the earlier pTau181...
Virologist Accused of Starting COVID-19 Will Fight U.S. Ban on Funding
The U.S. Department of Health and Human Services has moved to debar Ralph Baric, a leading coronavirus virologist at UNC, cutting off his federal funding for at least three years. The action stems from accusations that Baric’s 2014 mouse experiments with...
BMS Partners with Hengrui Pharma in a Potential ~$15.2B Deal to Advance 13 Early-Stage Programs Across Oncology, Hematology, and Immunology
Bristol‑Myers Squibb (BMS) has struck a strategic partnership with China’s Hengrui Pharma to advance 13 early‑stage programs covering oncology, hematology and immunology. Hengrui will lead early clinical development while BMS receives exclusive ex‑China rights to the assets, and Hengrui secures...
My Presentation of 3/11 Viral Takeover to Doctors for COVID Ethics
Sonia Elijah, an investigative journalist, presented her debut book *3/11 Viral Takeover*, a forensic examination of the COVID‑19 pandemic response. She detailed how a coordinated narrative—shaped by influential scientists and officials like Fauci, Collins, and the WHO—promoted lockdowns, rushed vaccine...
The $262B “Acceptance”: Why It’s Time to Stop Treating Denials as an Unavoidable Cost
Dr. Wael Khouli warns that the $262 billion in denied hospital claims is not an inevitable cost. About 15% of claims are rejected, yet 70% of appealed ones could be overturned, while hospitals waste $19.7 billion on manual denial management. He attributes...
Tomatidine Boosts Memory and Cuts Cellular Aging in Mice
Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged mice https://t.co/jVfshXgzxQ https://t.co/6l86CBdoBC
Bioxyne Signs $50m Exclusive German Supply Deal with ADREX
Australian biotech Bioxyne (ASX: BXN) has signed an exclusive $50 million supply agreement with German distributor ADREXpharma, covering GMP‑certified cannabis flower and related products. The contract includes a $25 million minimum purchase commitment in the first year and an automatic 12‑month renewal,...
Hantavirus Outbreak Research: Trump Administration Shut Down Study Last Year on Rodent-to-Human Transmission
In 2025 the Trump administration terminated funding for a pilot project that examined how hantavirus moves from rodents to humans. The study, run by the West African Center for Emerging Infectious Diseases, was part of the ten‑site CREID network that...
“Evidence for Puberty Suppression and Gender Affirming Hormones Limited’: British Doctors Group Questions Early Transitions but Also Opposes Blocker Ban
The British Medical Association (BMA) released a critique of the Cass review, reaffirming that the scientific evidence for puberty suppression and gender‑affirming hormones in young people is limited and uncertain. While the BMA acknowledges genuine risks such as osteoporosis and...
China Blocks Taiwan From WHO, Taiwan Still Attends
Reuters: China said on Monday it would not allow Taiwan to take part in the annual assembly of the World Health Organisation, which starts next week, as Taiwan said it would send a delegation anyway for meetings outside the actual...
Anti-Vax Activists Falsely Blame COVID Vaccines for the Rising U.S. Cancer Rate Among Younger People.
The National Cancer Institute released data covering 2000‑2023 that show a steady rise in early‑onset cancers—those diagnosed in people under 50—in the United States. Anti‑vaccine activists seized on a 6.37% increase recorded between 2021 and 2023, a period coinciding with...
Diagnosing the Future: Proteins, Biosensors and Fundamental Science with Prof. Eleonora Macchia
In this episode, Prof. Eleonora Macchia discusses how fundamental research on protein interactions can be turned into ultra‑sensitive biosensors for early disease detection, highlighting her ERC project that moved from studying topological transitions of proteins to a clinical trial for pancreatic...
How Compassus Is Transforming Home Health Intake With AI
Compassus, a Tennessee‑based home health and hospice provider, has deployed an AI‑driven intake platform that slashes referral processing from roughly an hour to under ten minutes. The tool aggregates fax, email and EMR sources, automatically checks zip codes and insurance,...
Just Like Cigarettes, Vaping Likely Causes Cancer, Major Study Finds
A comprehensive 2026 review in the journal Carcinogenesis concluded that e‑cigarettes are likely to cause lung and oral cancer. The analysis integrated human biomarker data, laboratory experiments, and animal studies, all showing DNA damage, oxidative stress, inflammation, and tumor formation...
Nicotinamide Nanotubes Restore Brain Cell Energy After Acute Injury
Researchers reported that nicotinamide‑loaded peptoid nanotubes (NAM‑PNTs) restore cellular energy in acute neonatal brain injury models. The nanostructures deliver an NAD⁺ precursor directly to microglia, boosting ATP, reducing inflammatory cytokines, and improving tissue histology after a single systemic dose. Efficacy...